Conferences
Tuesday, February 24, 2015 Learn why government and private health plans are taking tougher actions to ensure that clinical labs and pathology groups are complying with laws, regulations, and managed care contract terms Distinguished...
Visit Definiens at booth #423 at the Molecular Med-Tri-Con conference, February 16-18 to learn about Definiens’ comprehensive range of digital and molecular pathology solutions for imaging and quantifying biomarkers in tissue sections. At...
The University of Pittsburgh Medical Center’s Liron Pantanowitz, Douglas Hartman, and Jeffrey Fine discuss the future of digital pathology, what they are most looking forward to at CHI’s Digital Pathology conference, changes in the field,...
PathXL today announced it will unveil a significant upgrade to its award-winning product, TissueMark®, which will now include a powerful add-on for cell counting. The formal announcement will take place at the forthcoming Global Engage Digital...
New Mexico, USA 12/2/2014 - Indica Labs announced today that its HALO™ image analysis platform was used to quantify predictive biomarkers in a ground breaking study of the melanoma drug, pembrolizumab. Pembrolizumab is an immunotherapy...
